{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:33:53Z","timestamp":1790303633494,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Women with aggressive triple-negative breast cancer (TNBC) are at high risk of brain metastasis, which has no effective therapeutic option partially due to the poor penetration of drugs across the blood\u2212brain barrier. Trifluoperazine (TFP) is an approved antipsychotic drug with good bioavailability in brain and had shown anticancer effect in several types of cancer. It drives us to investigate its activities to suppress TNBC, especially the brain metastasis. In this study, we chose three TNBC cell lines MDA-MB-468, MDA-MB-231, and 4T1 to assess its anticancer activities along with the possible mechanisms. In vitro, it induced G0\/G1 cell cycle arrest via decreasing the expression of both cyclinD1\/CDK4 and cyclinE\/CDK2, and stimulated mitochondria-mediated apoptosis. In vivo, TFP suppressed the growth of subcutaneous xenograft tumor and brain metastasis without causing detectable side effects. Importantly, it prolonged the survival of mice bearing brain metastasis. Immunohistochemical analysis of Ki67 and cleaved caspase-3 indicated TFP could suppress the growth and induce apoptosis of cancer cells in vivo. Taken together, TFP might be a potential available drug for treating TNBC with brain metastasis, which urgently needs novel treatment options.<\/jats:p>","DOI":"10.1038\/s41419-018-1046-3","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T14:45:48Z","timestamp":1537973148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Zhanzhan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"1046_CR1","first-page":"2247","volume":"70","author":"R Ismail-Khan","year":"2015","unstructured":"Ismail-Khan, R., Minton, S. & Khakpour, N. Triple-negative breast cancer. Drugs 70, 2247\u20132258 (2015).","journal-title":"Drugs"},{"key":"1046_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics 2016. CA Cancer J. Clin. 66, 7\u201330 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"1046_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3896","volume":"15","author":"EC Dietze","year":"2015","unstructured":"Dietze, E. C., Sistrunk, C., Miranda-Carboni, G., O\u2019Regan, R. & Seewaldt, V. L. Triple-negative breast cancer in African-American women: disparities versus biology. Nat. Rev. Cancer 15, 248\u2013254 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1046_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/OTT.S67673","volume":"8","author":"F Tomao","year":"2015","unstructured":"Tomao, F. et al. Triple-negative breast cancer: new perspectives for targeted therapies. OncoTargets Ther. 8, 177\u2013193 (2015).","journal-title":"OncoTargets Ther."},{"key":"1046_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","volume":"76","author":"A Ranjan","year":"2016","unstructured":"Ranjan, A., Gupta, P. & Srivastava, S. K. Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis. Cancer Res. 76, 877\u2013890 (2016).","journal-title":"Cancer Res."},{"key":"1046_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 13, 674\u2013690 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1046_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10585-007-9071-0","volume":"24","author":"O Mendes","year":"2007","unstructured":"Mendes, O., Kim, H. T., Lungu, G. & Stoica, G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1\/2. Clin. Exp. Metastas-. 24, 341\u2013351 (2007).","journal-title":"Clin. Exp. Metastas-."},{"key":"1046_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ccell.2015.01.001","volume":"27","author":"DP Kodack","year":"2015","unstructured":"Kodack, D. P., Askoxylakis, V., Ferraro, G. B., Fukumura, D. & Jain, R. K. Emerging strategies for treating brain metastases from breast cancer. Cancer Cell. 27, 163\u2013175 (2015).","journal-title":"Cancer Cell."},{"key":"1046_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.breast.2014.06.009","volume":"23","author":"C Aversa","year":"2014","unstructured":"Aversa, C. et al. Metastatic breast cancer subtypes and central nervous system metastases. Breast 23, 623\u2013628 (2014).","journal-title":"Breast"},{"key":"1046_CR10","doi-asserted-by":"publisher","first-page":"S461","DOI":"10.1097\/01.JTO.0000391366.63882.30","volume":"5","author":"DR Camidge","year":"2010","unstructured":"Camidge, D. R. Cell cycle-associated kinases as targets for therapy in lung cancer. J. Thorac. Oncol. 5, S461\u2013S462 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pharmthera.2013.01.011","volume":"138","author":"S Diaz-Moralli","year":"2013","unstructured":"Diaz-Moralli, S., Tarrado-Castellarnau, M., Miranda, A. & Cascante, M. Targeting cell cycle regulation in cancer therapy. Pharmacol. Ther. 138, 255\u2013271 (2013).","journal-title":"Pharmacol. Ther."},{"key":"1046_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"1046_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","volume":"36","author":"K Vermeulen","year":"2003","unstructured":"Vermeulen, K., Van Bockstaele, D. R. & Berneman, Z. N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferat 36, 131\u2013149 (2003).","journal-title":"Cell Proliferat"},{"key":"1046_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.canlet.2014.09.042","volume":"355","author":"Y Xia","year":"2014","unstructured":"Xia, Y. et al. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2\/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo. Cancer Lett. 355, 297\u2013309 (2014).","journal-title":"Cancer Lett."},{"key":"1046_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11010-010-0709-x","volume":"351","author":"MS Ola","year":"2011","unstructured":"Ola, M. S., Nawaz, M. & Ahsan, H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell. Biochem. 351, 41\u201358 (2011).","journal-title":"Mol. Cell. Biochem."},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cytogfr.2008.04.001","volume":"19","author":"A Ashkenazi","year":"2008","unstructured":"Ashkenazi, A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 19, 325\u2013331 (2008).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1046_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","volume":"34","author":"SC Gupta","year":"2013","unstructured":"Gupta, S. C., Sung, B., Prasad, S., Webb, L. J. & Aggarwal, B. B. Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends Pharmacol. Sci. 34, 508\u2013517 (2013).","journal-title":"Trends Pharmacol. Sci."},{"key":"1046_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.bjc.6603259","volume":"95","author":"SO Dalton","year":"2006","unstructured":"Dalton, S. O. et al. Cancer risk among users of neuroleptic medication: a population-based cohort study. Br. J. Cancer 95, 934\u2013939 (2006).","journal-title":"Br. J. Cancer"},{"key":"1046_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1600-0447.1987.tb02928.x","volume":"76","author":"J Ravn","year":"1987","unstructured":"Ravn, J. Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiat Scand. 76, 585\u2013590 (1987).","journal-title":"Acta Psychiat Scand."},{"key":"1046_CR20","first-page":"811","volume":"2","author":"QY Chen","year":"2009","unstructured":"Chen, Q. Y. et al. Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol. Med. Rep. 2, 811\u2013817 (2009).","journal-title":"Mol. Med. Rep."},{"key":"1046_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.271.5248.499","volume":"271","author":"F Fang","year":"1996","unstructured":"Fang, F., Orend, G., Watanabe, N., Hunter, T. & Ruoslahti, E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271, 499\u2013502 (1996).","journal-title":"Science"},{"key":"1046_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature03094","volume":"432","author":"J Massagu\u00e9","year":"2004","unstructured":"Massagu\u00e9, J. G1 cell-cycle control and cancer. Nature 432, 298\u2013306 (2004).","journal-title":"Nature"},{"key":"1046_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2012.03.004","volume":"322","author":"XJ Yu","year":"2012","unstructured":"Yu, X. J. et al. Gambogenic acid induces G1 arrest via GSK3beta-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells. Cancer Lett. 322, 185\u2013194 (2012).","journal-title":"Cancer Lett."},{"key":"1046_CR24","doi-asserted-by":"crossref","first-page":"42110","DOI":"10.18632\/oncotarget.9881","volume":"7","author":"SH Park","year":"2015","unstructured":"Park, S. H. et al. Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo. Oncotarget 7, 42110\u201342125 (2015).","journal-title":"Oncotarget"},{"key":"1046_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35037710","volume":"407","author":"MO Hengartner","year":"2000","unstructured":"Hengartner, M. O. The biochemistry of apoptosis. Nature 407, 770\u2013776 (2000).","journal-title":"Nature"},{"key":"1046_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/ars.2008.2270","volume":"11","author":"MB Azad","year":"2009","unstructured":"Azad, M. B., Chen, Y. & Gibson, S. B. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid. Redox Signal. 11, 777\u2013790 (2009).","journal-title":"Antioxid. Redox Signal."},{"key":"1046_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1191\/0960327102ht213oa","volume":"21","author":"KR Martin","year":"2002","unstructured":"Martin, K. R. & Barrett, J. C. Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol. 21, 71\u201375 (2002).","journal-title":"Hum. Exp. Toxicol."},{"key":"1046_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu, M. L. & Aw, T. Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Bio. Med. 48, 749\u2013762 (2010).","journal-title":"Free Radic. Bio. Med."},{"key":"1046_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1009616228304","volume":"5","author":"HU Simon","year":"2000","unstructured":"Simon, H. U., Hajyehia, A. & Levischaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415\u2013418 (2000).","journal-title":"Apoptosis"},{"key":"1046_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-5-10","volume":"5","author":"SK Roy","year":"2010","unstructured":"Roy, S. K., Srivastava, R. K. & Shankar, S. Inhibition of PI3K\/AKT and MAPK\/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J. Mol. Signal. 5, 10 (2010).","journal-title":"J. Mol. Signal."},{"key":"1046_CR31","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang, F. et al. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17, 590\u2013603 (2003).","journal-title":"Leukemia"},{"key":"1046_CR32","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1038\/sj.onc.1208713","volume":"24","author":"F Vandermoere","year":"2005","unstructured":"Vandermoere, F., Yazidibelkoura, I. E., Adriaenssens, E., Lemoine, J. & Hondermarck, H. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappa B activation induced via interaction between Akt and I kappa B kinase-beta in breast cancer cells. Oncogene 24, 5482\u20135491 (2005).","journal-title":"Oncogene"},{"key":"1046_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-012-2175-5","volume":"135","author":"T Zhang","year":"2012","unstructured":"Zhang, T. et al. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion. Breast Cancer Res. Treat. 135, 445\u2013458 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"1046_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/s110100180","volume":"11","author":"MC Dan","year":"2010","unstructured":"Dan, M. C., Xu, T., Sayler, G. S. & Ripp, S. In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors 11, 180\u2013206 (2010).","journal-title":"Sensors"},{"key":"1046_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","volume":"8","author":"S Cleator","year":"2007","unstructured":"Cleator, S., Heller, W. & Coombes, R. C. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 8, 235\u2013244 (2007).","journal-title":"Lancet Oncol."},{"key":"1046_CR36","first-page":"307","volume":"7","author":"NU Lin","year":"2013","unstructured":"Lin, N. U. Breast cancer brain metastases:new directions in systemic therapy. Ecancermedicalscience 7, 307 (2013).","journal-title":"Ecancermedicalscience"},{"key":"1046_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7314\/APJCP.2014.15.1.489","volume":"15","author":"L Wu","year":"2014","unstructured":"Wu, L. et al. Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis. Asian Pac. J. Cancer Prev. 15, 489\u2013494 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1046_CR38","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","volume":"34","author":"SY Shin","year":"2013","unstructured":"Shin, S. Y. et al. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells. Carcinogenesis 34, 2080\u20132089 (2013).","journal-title":"Carcinogenesis"},{"key":"1046_CR39","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1158\/1535-7163.MCT-06-0402","volume":"6","author":"AG Polischouk","year":"2007","unstructured":"Polischouk, A. G. et al. The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non small cell lung carcinoma cells to DNA double-strand break induced cell death. Mol. Cancer Ther. 6, 2303\u20132309 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"1046_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/emm.2004.50","volume":"36","author":"SY Shin","year":"2004","unstructured":"Shin, S. Y., Chang, G. K., Dong, D. H., Kim, J. H. & Lee, Y. H. Implication of Egr-1 in trifluoperazine-induced growth inhibition in human U87MG glioma cells. Exp. Mol. Med. 36, 380\u2013386 (2004).","journal-title":"Exp. Mol. Med."},{"key":"1046_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejps.2006.03.002","volume":"28","author":"SY Shin","year":"2006","unstructured":"Shin, S. Y., Choi, B. H., Kim, J. R., Kim, J. H. & Lee, Y. H. Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells. Eur. J. Pharm. Sci. 28, 300\u2013306 (2006).","journal-title":"Eur. J. Pharm. Sci."},{"key":"1046_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-016-0675-z","volume":"77","author":"ES Kim","year":"2017","unstructured":"Kim, E. S. Abemaciclib: first global approval. Drugs 77, 1\u20138 (2017).","journal-title":"Drugs"},{"key":"1046_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11523-017-0492-7","volume":"12","author":"ES Kim","year":"2017","unstructured":"Kim, E. S. & Scott, L. J. Palbociclib: a review in HR-positive, HER2-negative, advanced or metastatic breast cancer. Target Oncol. 12, 373\u2013383 (2017).","journal-title":"Target Oncol."},{"key":"1046_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/gyno.2001.6308","volume":"83","author":"L Sui","year":"2001","unstructured":"Sui, L. et al. Implication of malignancy and prognosis of p27 (kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors. Gynecol. Oncol. 83, 56\u201363 (2001).","journal-title":"Gynecol. Oncol."},{"key":"1046_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1615\/CritRevOncog.v7.i1-2.80","volume":"7","author":"G Delsal","year":"1996","unstructured":"Delsal, G., Loda, M. & Pagano, M. Cell cycle and cancer: critical events at the G1 restriction point. Crit. Rev. Oncog. 7, 127\u2013142 (1996).","journal-title":"Crit. Rev. Oncog."},{"key":"1046_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/45836","volume":"401","author":"CH Spruck","year":"1999","unstructured":"Spruck, C. H., Won, K. A. & Reed, S. I. Deregulated cyclin E induces chromosome instability. Nature 401, 297\u2013300 (1999).","journal-title":"Nature"},{"key":"1046_CR47","first-page":"11","volume":"6","author":"T Mishina","year":"2000","unstructured":"Mishina, T. et al. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin. Cancer Res. 6, 11\u201316 (2000).","journal-title":"Clin. Cancer Res."},{"key":"1046_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrd2907","volume":"8","author":"S Lapenna","year":"2009","unstructured":"Lapenna, S. & Giordano, A. Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 8, 547\u2013566 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1046_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/030098589803500601","volume":"35","author":"KA Schafer","year":"1998","unstructured":"Schafer, K. A. The cell cycle: a review. Vet. Pathol. 35, 461\u2013478 (1998).","journal-title":"Vet. Pathol."},{"key":"1046_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/MCB.19.1.612","volume":"19","author":"JM Gudas","year":"1999","unstructured":"Gudas, J. M. et al. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol. Cell. Biol. 19, 612\u2013622 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"1046_CR51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0962-8924(02)02352-8","volume":"12","author":"T Burdon","year":"2002","unstructured":"Burdon, T., Smith, A. & Savatier, P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12, 432\u2013438 (2002).","journal-title":"Trends Cell Biol."},{"key":"1046_CR52","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1159\/000358665","volume":"33","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y. et al. A novel small-molecule YLT205 induces apoptosis in human colorectal cells via mitochondrial apoptosis pathway in vitro and inhibits tumor growth in vivo. Cell. Physiol. Biochem. 33, 933\u2013944 (2014).","journal-title":"Cell. Physiol. Biochem."},{"key":"1046_CR53","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1038\/sj.onc.1208825","volume":"24","author":"SJ Jeong","year":"2005","unstructured":"Jeong, S. J., Pisemasison, C. A., Radonovich, M. F., Park, H. U. & Brady, J. N. Activated AKT regulates NF-kappa B activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24, 6719\u20136728 (2005).","journal-title":"Oncogene"},{"key":"1046_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1096\/fasebj.15.1.2","volume":"15","author":"I Tegeder","year":"2001","unstructured":"Tegeder, I. et al. Inhibition of NF-kB and AP-1 activation by R- and S-flurbiprofen. Faseb J. 15, 2\u20134 (2001).","journal-title":"Faseb J."},{"key":"1046_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.63","volume":"6","author":"F Yang","year":"2015","unstructured":"Yang, F. et al. Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model. Cell Death Dis. 6, e1701 (2015).","journal-title":"Cell Death Dis."},{"key":"1046_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527, 100\u2013104 (2015).","journal-title":"Nature"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1046-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:20:10Z","timestamp":1671538810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1046-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"10 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1006"}}